Roivant Sciences' Venker sells 158,194-share block
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Roivant Sciences Ltd. (ROIV) officer Eric Venker, identified as President & Immunovant CEO, sold 158,194 common shares at a weighted average price of $40.44 on November 10, 2026. He also sold 29,749 common shares at a weighted average price of $41.00 that day. Both sales were made under a Rule 10b5-1 trading plan adopted June 30, 2026.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares F1 | 158,194 | $40.44 | $6.40M |
| Sale | Common Shares F2 | 29,749 | $41.00 | $1.22M |
Footnotes (2)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 to $40.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.93 to $41.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on June 30, 2026.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.